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Abstract. 
 
The caspase-dependent activation of cyclin-
dependent kinases (Cdks) in varied cell types in re-
sponse to disparate suicidal stimuli has prompted our 
examination of the role of Cdks in cell death. We have 
tested the functional role of Cdk activity in cell death 
genetically, with the expression of dominant negative 
Cdk mutants (DN-Cdks) and Cdk inhibitory genes. 
Here we demonstrate that Cdk2 activity is necessary 
for death-associated chromatin condensation and other 
manifestations of apoptotic death, including cell shrink-
age and the loss of adhesion to substrate. Susceptibility 
to the induction of the cell death pathway, including the 
activation of the caspase cascade, is unimpaired in cells 
in which Cdk2 activity is inhibited. The direct visualiza-
tion of active caspase activity in these cells conﬁrms 
that death-associated Cdk2 acts downstream of the 
caspase cascade. Cdk inhibition also does not prevent 
the loss of mitochondrial membrane potential and 
membrane phospholipid asymmetry, which may be di-
rect consequences of caspase activity, and dissociates 
these events from apoptotic condensation. Our data 
suggest that caspase activity is necessary, but not sufﬁ-
cient, for the full physiological cell death program and 
that a requisite function of the proteolytic caspase cas-
cade is the activation of effector Cdks.
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Introduction
 
Recent studies reveal that a thematically conserved path-
way, comprised of the functionally ordered products of ex-
panded gene families, effects physiological cell death,
leading to the characteristic morphology of apoptosis (El-
lis and Horvitz, 1986; Boise et al., 1993; Oltvai et al., 1993;
Chinnaiyan et al., 1996; Enari et al., 1996; Harvey et al.,
1998; Hirata et al., 1998). Among the most prominent hall-
marks of physiological cell death are prelytic nuclear
events, including chromatin condensation, genome diges-
tion, and breakdown of the nuclear envelope (Russell et al.,
1980; Wyllie, 1980; Ucker et al., 1992). Other markers of
the physiological cell death response have been described,
including plasma membrane reorganization associated
with blebbing, shrinkage, and the loss of membrane phos-
phatidylserine asymmetry (Kerr et al., 1972; Fadok et al.,
1992). Mitochondrial integrity is compromised during the
death process as well, and involves the release of cyto-
chrome 
 
c
 
 and the loss of membrane potential (
 
DC
 
m
 
; Susin
et al., 1997; Yang et al., 1997). It remains still to be deter-
mined what specific molecular events are responsible for
the demise of the cell and where, within the conserved
pathway, the irreversible commitment to lethality occurs.
Nuclear events during cell death parallel processes that
occur in viable cells during the mitotic cell cycle (Ucker,
1991). That many stimuli that induce cell proliferation also
can trigger death suggests that the mechanisms that con-
trol the fundamental biological processes of mitosis and
apoptosis are related. The induction of physiological cell
death under conditions of trophic factor deprivation (Ga-
laktionov et al., 1996; Luo et al., 1996) and in post-mitotic
cells (Al-Ubaidi et al., 1992; Feddersen et al., 1992), and
the activation-driven deletion of lymphocytes (Fournel et
al., 1996; Radvanyi et al., 1996; Hakem et al., 1999) depend
on the function of molecules of the productive cell cycle
and exemplify this close interplay.
The molecular engines of the cell cycle, first defined
genetically in yeast and now well characterized in mam-
malian cells, are composed of cyclin-dependent kinases
(Cdks
 
1
 
; Riabowol et al., 1989; Meyerson et al., 1992). Mul-
tiple modes of regulation, especially on the posttransla-
 
Address correspondence to David S. Ucker, Department of Microbiology
and Immunology, University of Illinois College of Medicine, Rm. E803
(M/C 790), 835 South Wolcott, Chicago, IL 60612. Tel.: (312) 413-1102.
Fax: (312) 996-6415. E-mail: duck@uic.edu
 
1
 
Abbreviations used in this paper:
 
 
 
DC
 
m
 
, mitochondrial membrane poten-
tial; Cdk, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibi-
tor; ClCCP, carbonyl cyanide 
 
m
 
-chlorophenylhydrazone; DEVD, Asp-
Glu-Val-Asp; DN-Cdk, dominant negative cyclin-dependent kinase;
EGFP-F, enhanced GFP that includes a sequence for farnesylation; GFP,
green fluorescent protein; IETD, Iso-Glu-Thr-Asp; MCA, 4-methyl-cou-
maryl-7-amide; PE, phycoerythrin; TMRE, tetramethyl rhodamine ethyl
ester; YVAD, Tyr-Val-Ala-Asp. 
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tional level, pertain to the cell cycle–specific control of
Cdk activity. Cdks are inactive unless complexed with their
periodically synthesized cognate cyclins (Solomon et al.,
1990). Reversible phosphorylations at distinct sites acti-
vate and inhibit kinase activity (Russell and Nurse, 1987;
Strausfeld et al., 1991; Heald et al., 1993). Cyclin-depen-
dent kinase inhibitors (CKIs), including members of the
Cip/Kip and Ink4 families, are involved in assembling
and inactivating Cdk complexes (Polyak et al., 1994;
Toyoshima and Hunter, 1994; Brugarolas et al., 1995; Ser-
rano et al., 1996). Finally, the subcellular localization of
Cdks and their regulators restrict the activation of Cdks to
appropriate temporal and spatial compartments (Heald et
al., 1993; Diehl and Sherr, 1997; Jin et al., 1998).
In contrast, the identities of the molecular elements that
drive the cell death process are not elaborated fully. Ge-
netic studies of developmental cell death in the worm 
 
C
 
.
 
elegans
 
 have led to the identification and characterization
of elements of a singular and conserved death pathway
(Ellis and Horvitz, 1986). Cell death in 
 
C
 
.
 
 elegans
 
 is depen-
dent on the activation of Ced3, a member of the caspase
family of aspartate-specific cysteine proteases (Yuan et al.,
1993; Xue et al., 1996). Ced9, encoded by a homologue of
the 
 
bcl-2
 
 family of human oncogenes, inhibits 
 
ced3-
 
depen-
dent death and acts upstream of Ced3 in the cell death
pathway (Hengartner et al., 1992; Vaux et al., 1992; Hen-
gartner and Horvitz, 1994). Ced4 also acts upstream of
Ced3 and is required for death (Shaham and Horvitz,
1996). Mammalian proteins with partial similarity to Ced4
activate mammalian caspases; Apaf1, for example, acti-
vates caspase 9 in the presence of cytochrome 
 
c
 
 (Li et al.,
1997; Zou et al., 1997). One of the limitations of these ge-
netic studies is their reliance on mutations with uncondi-
tional death-resistance phenotypes. Screens for uncondi-
tional mutants preclude the identification of genes that are
necessary both for viability and for death.
The basic molecular framework for regulating and exe-
cuting cell death appears to be conserved in mammalian
cells. In contrast to worms, however, death in mammalian
cells is characterized by diverse initiating signals and mul-
tiple death-regulating members of both the caspase and
 
bcl-2
 
 gene families (Oltvai and Korsmeyer, 1994; Minn
et al., 1996; Salvesen and Dixit, 1997). Each caspase is syn-
thesized as a pro-enzyme and activated by cleavage at in-
ternal sites, potentially by the same or another caspase
class (Thornberry et al., 1992; Nicholson et al., 1995).
Caspases function within a proteolytic cascade that is
punctuated by members of the Bcl-2 family (Enari et al.,
1995; Harvey et al., 1998). Bcl-2 seems to regulate the acti-
vation of downstream caspases, possibly through the com-
partmentalization of activating factors such as cytochrome
 
c
 
 without directly affecting the activity of upstream cas-
pases (Kluck et al., 1997; Yang et al., 1997; Harvey et al.,
1998). Caspases that act upstream of the sparing function
of Bcl-2 have been characterized as initiators of the cell
death response; caspases that act downstream of Bcl-2
have been designated as effectors of cell death (Harvey
et al., 1998). The functional assignments thus made have
been supported generally by gene structure analysis, as
well as by groupings based on substrate specificities
(Thornberry et al., 1997; Van de Craen et al., 1997). Initia-
tor pro-caspases contain long pro-domains that facilitate
 
their oligomerization and activation by cell surface mole-
cules, such as the TNF-
 
a
 
 “death receptor”, or by intracel-
lular death regulators such as Apaf1 (Chinnaiyan et al.,
1995; Fernandes-Alnemri et al., 1996). The effector pro-
caspases, in contrast, possess only short pro-domains and
are activated within the proteolytic cascade by upstream
caspases (Li et al., 1997; Slee et al., 1999).
Although the activation of the caspase cascade has been
recognized as necessary for the physiological cell death
process, the essential death substrates and lethal biochem-
ical events that are targeted have not been identified
(Wang et al., 1995; Rao et al., 1996; MacFarlane et al.,
1997; Zhang et al., 1998). We and others have described
the activation of Cdks as a common, caspase-dependent
attribute of the physiological cell death process, and have
hypothesized that it is important for the cell death re-
sponse (Harvey et al., 1998; Levkau et al., 1998; Zhou et
al., 1998).
To explore the role of Cdk activity within the cell death
process, we have examined death responses in cells in
which we have manipulated Cdk activity genetically. Here
we show that death-associated Cdk activity is necessary
for a variety of cell death events including chromatin con-
densation, and that it functions downstream of the caspase
cascade in a conserved death pathway. The proteolytic
caspase cascade facilitates the activation of effector Cdks,
but is not itself sufficient for the complete cell death pro-
gram.
 
Materials and Methods
 
Strategy for the Tracking and Analysis of
Transfected Cells
 
We have employed a green fluorescent protein (GFP) variant as a marker
to visualize transfected cells directly. Soluble GFP leaks from dying cells
(Harvey, K.J., unpublished observations); in addition, it is not useful in
cytofluorimetric DNA analyses where ethanol fixation is required (Jiang
and Hunter, 1998). In contrast, a membrane-targeted GFP, the genetic fu-
sion of the enhanced green fluorescent protein and the farnesylation se-
quence of p21
 
Ras
 
 (EGFP-F; Jiang and Hunter, 1998), is retained preferen-
tially in unfixed dying cells (Harvey, K.J., unpublished data). Using this
marker, we have been able to identify transfectants consistently, indepen-
dent of their ultimate fate. Moreover, we find that the cell rounding and
shrinkage associated with the loss of adhesion during cell death results in a
condensed EGFP-F signal: an increased intensity of green fluorescence
per cell surface area, presumably resulting from the retention and concen-
tration of EGFP-F in dying cells with reduced volume (see Fig. 3). EGFP-F
condensation serves as a quantitative and reliable correlate of cellular col-
lapse.
 
Cellular Procedures and Analyses
 
Cell Culture and Synchronization. 
 
Freshly cloned populations of HeLa
cells were grown in DME medium (Mediatech) supplemented with heat
inactivated fetal calf serum (10% v/v; HyClone Laboratories) and 2 mM
 
L
 
-glutamine (Mediatech). Two methods of synchronization were employed.
We used the double thymidine block method of Rao and Engelberg,
(1966). Cells were incubated in complete medium supplemented with
2.5 mM thymidine (Sigma Chemical Co.) for 16 h, released into medium
without thymidine for 9 h, and then treated with thymidine for an addi-
tional 16 h. Cells also were starved of serum by culturing in media contain-
ing 0.2% fetal calf serum for 48 h. These treatments alone did not cause
cell death.
 
Transfections. 
 
The constructs employed include: pcDNA3, CrmA/
pcDNA3 and p35/pcDNA3 (Tewari et al., 1995), pSFFV-Neo/Bcl-2
(Hockenbery et al., 1990), pCMVp16-Ink4a (David Beach, Cold Spring
Harbor Laboratory), pBabe-p21
 
Cip1/Waf1
 
-GFP (Hiroaki Kiyokawa, Univer- 
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sity of Illinois, Chicago), pCMV5/Kip-p27 (Kiyokawa et al., 1996), pCMV-
p21
 
Cip1/Waf1
 
D
 
17-52-HA  (Robles et al., 1998), and pCMV-Cdk{1-4}-DN
(van den Heuvel and Harlow, 1993). 6 
 
m
 
g of each construct or empty vec-
tor was cotransfected into 10
 
5
 
 HeLa cells seeded the night before in six-
well plates using a standard calcium phosphate precipitation method with
0.6 
 
m
 
g of EGFP-F (Jiang and Hunter, 1998; a kind gift of Eve Shinbrot,
Clontech Laboratories, Palo Alto, CA) as a transfection marker. After 16
h cells were washed free of precipitate and incubated in fresh media. We
routinely obtain transfection efficiencies with HeLa cells of 
 
z
 
35% (data
not shown). The transfection procedure itself also induces a low level
(
 
,
 
10%) of cell death in the entire population (including both EGFP-F
 
1
 
cells that have successfully expressed transfected DNA and those that
have not). We have noted that the death-inhibitory effects of gene prod-
ucts such as Bcl-2 can be observed as a specific reduction of this back-
ground death among the EGFP-F
 
1
 
 cells; conversely, death-inducing gene
products, such as p16
 
Ink4a
 
, enhance background death specifically among
the EGFP-F
 
1
 
 cells.
 
Cell Cycle Analysis. 
 
48 h after transfection, cell cycle analysis was per-
formed by staining with propidium iodide (Krishan, 1975). We have found
that some farnesylated green fluorescent protein from transfectants is sol-
ubilized upon fixation in ethanol. Inclusion of a low concentration of BSA
in all aqueous buffers is necessary to prevent EGFP-F from sticking non-
specifically to untransfected cells after ethanol fixation (Harvey, K.J., and
D.S. Ucker; unpublished data). In brief, 10
 
6
 
 cells were washed twice with
PBS supplemented with 0.2% BSA and fixed in one ml of 50% ethanol for
30 min on ice. Cells were pelleted and treated in the dark with 1 mg/ml of
RNase A and 50 
 
m
 
g/ml of propidium iodide in 400 
 
m
 
l PBS/BSA for 30 min
at 25
 
8
 
C. Stained cells were analyzed cytofluorimetrically on a FacsCali-
ber™ instrument (Beckton Dickinson). Cell cycle distributions were
quantified using ModFit software (Verity Software House).
 
Death Induction. 
 
48 h after transfection, cells were induced to die with
1 
 
m
 
M staurosporine (Sigma Chemical Co.), 10 ng/ml TNF-
 
a
 
 (a generous
gift of Dale Hales, University of Illinois, Chicago), 100 ng/ml of actinomy-
cin D (Sigma Chemical Co.), or 200 
 
m
 
M carbonyl cyanide 
 
m
 
-chlorophe-
nylhydrazone (ClCCP; kindly provided by Dale Hales). Sensitivity of
HeLa cells to TNF-
 
a
 
 is enhanced in the presence of a nonlethal dose of cy-
cloheximide; 3 
 
m
 
g/ml cycloheximide (Sigma Chemical Co.) was added si-
multaneously with TNF-
 
a
 
 in all cases.
 
Assessment of Chromatin Condensation. 
 
After incubation with 1 
 
m
 
g/ml
of Hoechst 33342 (Sigma Chemical Co.; Ex 
 
5 
 
355 nm; Em 
 
5 
 
465 nm) for
10 min at 37
 
8
 
C, chromatin was visualized in transfectant cells with a Nikon
Diaphot 200 microscope with epi-fluorescence. EGFP-F fluorescence was
detected in parallel (Ex 
 
5 
 
490 nm; Em 
 
5 
 
525 nm). Digital images were ac-
quired with a SenSys CCD Camera (Photometrics). Images were analyzed
using Image-Pro Plus (Media Cybernetics). Chromatin condensation was
scored among EGFP-F
 
1
 
 transfectants that exhibited at least a twofold in-
crease in pixel intensity of the Hoechst 33342 signal. For each sample, 3
fields with at least 100 cells each were counted.
 
Assessment of Cell Shrinkage, Rounding, and Condensation. 
 
The mani-
festations of typical apoptotic morphology in adherent HeLa cells, which
includes shrinkage and cell rounding, were visualized by phase contrast
microscopy. In addition, dying transfectant cells reliably displayed a con-
densed pattern of EGFP-F fluorescence. EGFP-F condensation was quan-
tified from digital images of transfected cells as an increase in pixel inten-
sity. In all cases analyzed, EGFP-F condensation strictly correlated with
chromatin condensation as measured by Hoechst staining of nuclei (Har-
vey, K.J., unpublished data).
 
Analysis of Caspase Activity In Vivo. 
 
HeLa cells were transfected as de-
scribed above and replated after 16 h onto micro plates with a coverslip
bottom (Fisher Scientific). After an additional 32 h, cells were treated for
4 h with death stimuli as above, or left untreated. The medium was re-
placed with a minimal volume (100 
 
m
 
l) supplemented with the cell per-
meant pro-fluorescent DEVD-specific caspase substrate PhiPhiLux-G
 
2
 
D
 
2
 
(10 
 
m
 
M; Packard et al., 1996; Oncoimmunin) during the last hour of incu-
bation. Hoechst 33342 was added during the last 10 min to stain chroma-
tin, as above. Cells were washed gently three times in complete media.
Signals from PhiPhiLux-G
 
2
 
D
 
2
 
 (Ex 
 
5 
 
540 nm; Em 
 
5 
 
580 nm), EGFP-F,
and Hoechst were detected by fluorescence microscopy. For cytofluori-
metric analysis, transfectant populations were treated with death stimuli
for 3 h as usual. Cells then were harvested with PBS 
 
1
 
 4 mM Na
 
2
 
EDTA,
washed once with complete medium, and resuspended for an additional 1 h
of incubation at 37
 
8
 
C in 50 
 
m
 
l of medium supplemented with 10 
 
m
 
M
PhiPhiLux-G
 
2
 
D
 
2
 
. Cells were diluted into 450 
 
m
 
l of cold flow cytometry
buffer and analyzed within 30 min (Ex 
 
5 
 
488 nm; Em 
 
5 
 
585 nm).
 
Annexin V Staining. 
 
Cells were harvested with PBS 
 
1
 
 4 mM Na
 
2
 
EDTA
and washed twice with cold PBS. Cells were resuspended in 100 
 
m
 
l of
 
binding buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 2.5 mM CaCl
 
2
 
) and
incubated with 5 
 
m
 
l of phycoerythrin (PE)-conjugated annexin V (Phar-
Mingen) for 15 min in the dark at 25
 
8
 
C. After incubation, 400 
 
m
 
l of bind-
ing buffer was added per sample and cells were analyzed cytofluorimetri-
cally (Ex 
 
5 
 
488 nm; Em 
 
5 
 
585 nm).
 
Mitochondrial Membrane Potential. 
 
Mitochondrial membrane potential
was assessed simply with tetramethyl rhodamine ethyl ester (TMRE; Mo-
lecular Probes), a fluorescent dye rapidly responsive to mitochondrial
membrane potential (Farkas et al., 1989). TMRE was stored as a stock so-
lution at 25 mg/ml in DMSO; a fresh working solution (40 
 
m
 
M) was
prepared in medium. Cells were incubated in medium with 100 nM
TMRE for 10 min at 37
 
8
 
C. Cells were harvested and washed once with
PBS supplemented with 0.2% BSA. The TMRE signal (Ex 
 
5 
 
488 nm;
Em 
 
5 
 
585 nm) was analyzed either cytofluorimetrically or by fluorescence
microscopy. The difference in staining for cells with polarized and depo-
larized mitochondria typically is at least one order of magnitude.
 
In Vitro Procedures and Analyses
 
Analysis of Caspase Activity. 
 
Preparation of digitonin extracts in HKEB
(100 mM Hepes, pH 7.4, 10 mM MgCl
 
2
 
, 5 mM EGTA, 100 
 
m
 
M PMSF, 1
mM DTT, and 50 
 
m
 
M 
 
g
 
-S-ATP) and assays of caspase and Cdk activities
followed our previously described protocols (Harvey et al., 1998). Specific
caspase activities were assayed using fluorogenic 4-methyl-coumaryl-
7-amide (MCA)-derivatized reporter substrate peptides for caspase
1, Acetyl-Tyr-Val-Ala-Asp-4-methyl-coumaryl-7-amide (YVAD-MCA;
Thornberry et al., 1992; Peninsula Laboratories) caspase 8, Acetyl-Iso-
Glu-Thr-Asp-4-methyl-coumaryl-7-amide (IETD-MCA; Peptides Inter-
national) and caspase 3, Acetyl-Asp-Glu-Val-Asp-4-methyl-coumaryl-
7-amide (DEVD-MCA; Peptides International). Stock solutions of
peptide reagents, including derivatized inhibitors (Peptides Interna-
tional), were prepared in anhydrous DMSO.
 
Analysis of Cdk Activity.  
 
Cdk activity was assayed essentially as de-
scribed previously (Harvey et al., 1998), using a synthetic substrate pep-
tide derived from the site of histone H1 phosphorylation mediated by
Cdk1 (Cdc2; Promega). Reactions were stopped after 10 min by the addi-
tion of 5 
 
m
 
l of 5% H
 
3
 
PO
 
4
 
 and spotted on duplicate 1.5 
 
3
 
 1.5 cm squares of
P-81 paper, washed four times for 5 min in 1% H
 
3
 
PO
 
4
 
 and one time in ac-
etone, dried, and quantified by scintillation analysis. Immunodepletion
was accomplished by incubation of 100 
 
m
 
g of extract with 1 
 
m
 
g of antibody
specific for Cdk2 or other kinases (Santa Cruz Biotechnology) for 4 h at
4
 
8
 
C in 200 
 
m
 
l of HKEB. Immune complexes were cleared thrice by incu-
bation for 2 h with 20 
 
m
 
l of protein A agarose (Sigma Chemical Co.). Ki-
nase activity remaining in the supernatant was assayed as described
above.
 
Western Blot Analysis. 
 
Immunodepletion of Cdk components was con-
firmed by Western blot analysis of both supernatants and pellets. 20 
 
m
 
l of
the depleted extract and 1/10 of the resuspended pellet from the first
round of depletion were run on 15% polyacrylamide gels and transferred
to Immobilon
 
 P 
 
(Millipore). Antibodies specific for Cdk2 and cyclin A
(Santa Cruz Biotechnology) were used to detect depleted proteins. Immu-
noreactive bands were visualized by the luminol reaction (ECLplus; Am-
ersham). Cleavage of epitope-tagged p21
 
Cip1/Waf1
 
 also was analyzed by
Western blot, using an HA-epitope-specific antibody (HY11, Santa Cruz
Biotechnology) and antibody directed to a p21 NH
 
2
 
-terminal peptide
(amino acids 58–77; Oncogene Research Products), after electrophoresis
of extract proteins on 15% polyacrylamide gels.
 
Results
 
Cdk2 Activity Is Activated in a Caspase-dependent 
Manner during HeLa Cell Death
 
The constitutive expression of viral caspase inhibitors
CrmA and p35 in transfected cells, which confers pleiotro-
pic cell death resistance, has demonstrated the indispens-
able role of the proteolytic caspase cascade in the physio-
logical cell death process (Enari et al., 1995; Tewari et al.,
1995; Harvey et al., 1998). We have sought to test the role
of Cdks in cell death similarly, through the genetic inter-
ference of specific Cdk activity with dominant negative
Cdk mutants (DN-Cdks) and Cdk inhibitors (CKIs). Since 
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unconditional interference with Cdk activity would abro-
gate proliferation and preclude the recovery of stably
transfected cells (see below), we have expressed these in-
hibitory constructs transiently. To mark transfected cells,
we chose a green fluorescent protein (GFP) variant that
allows direct visualization without disruption or fixation.
Because soluble GFP leaks from dying cells (KJH, unpub-
lished data), we made use of a membrane-anchored GFP,
derived from a construct that includes a sequence for far-
nesylation (EGFP-F; Jiang and Hunter, 1998; see Materi-
als and Methods).
For these analyses, we selected a cell line that is both
readily transfectable and susceptible to a variety of physio-
logical death stimuli. HeLa cells meet these criteria: they
can be transfected at high efficiency (we typically have ob-
tained efficiencies of 35% or greater; see Materials and
Methods) and they are susceptible to death induced by
 
TNF-
 
a
 
, staurosporine, and high doses of inhibitors of mac-
romolecular synthesis, such as actinomycin D. When in-
duced to die, the cells undergo a typical physiological cell
death, exhibiting characteristic chromatin condensation,
cell shrinkage, and loss of adhesion (see below).
A common process of cell death, similar to that charac-
terized previously in T and B lymphocytes (Harvey et al.,
1998), is induced in HeLa cells by each of these suicidal
stimuli. It involves the ordered induction of upstream initi-
ator caspase activity, downstream effector caspase activity,
and Cdk activity (Fig. 1, A and B, and data not shown).
While YVAD-specific initiator caspase activity (Harvey
et al., 1998) is not detectable in cytoplasmic extracts from
Figure 1. Activation of effector caspase and caspase-dependent Cdk2 activities in dying HeLa cells. The kinetics of DEVD-specific
caspase activity (A) and Cdk activity (B) were monitored in extracts of synchronized HeLa cells (after a double thymidine block) after
the addition of 1 mM staurosporine in the absence (d) and presence (s) of the pan-caspase inhibitor z-VAD-fmk (100 mM). The ap-
pearance of death-associated Cdk activity in unsynchronized HeLa cells in the absence (.) and presence (,) of the pan-caspase inhibi-
tor z-VAD-fmk (100 mM) also is presented. The death-associated caspase-dependent Cdk activity from HeLa cells treated with stauro-
sporine for 8 h was characterized by immunodepletion analysis (C); only the results of depletion with one Cdk-2–specific antibody (j)
and one irrelevant antibody specific for protein kinase C-d (PKC-d, u; see Emoto et al., 1995) are presented here. A Western blot analysis
of the staurosporine-induced extract, using Cdk2- and cyclin A-specific antibodies, is presented in C: (a) mock-depleted extract, (b) ex-
tract depleted with Cdk2-specific antibody, (c) precipitated material from Cdk-2 depleted extract. Cdk2 and cyclin A bands are indi-
cated. Note that the cyclin A band in the right lane is masked by precipitating IgG heavy chain. 
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dying HeLa cells, we observe other upstream caspase ac-
tivities, such as cleavage of IETD-MCA, a specific sub-
strate for apical caspase 8 (data not shown). The induction
of death-associated Cdk activity in HeLa cells follows the
kinetics of downstream effector caspase activity (Fig. 1,
A and B). Chromatin condensation and other terminal
events of death also follow these kinetics.
The induction of death-associated Cdk activity is most
clearly evident in cells synchronized at the G
 
1
 
/S boundary
after a double thymidine block (Figs. 1 B and 2 F). In un-
synchronized HeLa cell populations, the initiation of a
death response triggers a rapid drop in basal Cdk activity
that precedes the induction of death-associated Cdk activ-
ity (Figs. 1 B and 2 A). In previous studies, we have de-
scribed post-mitotic cell cycle arrest as an early and com-
mon event of cell death (Ucker, 1991; Harvey et al., 1998).
Death responses in HeLa cells involve similar cell cycle ar-
rest (data not shown). We interpret the initial depletion of
Cdk activity to reflect this cessation of cell cycle progres-
sion.
Cdk2 has been implicated as the death-associated Cdk
in a variety of cells, including HeLa cells (Meikrantz et
al., 1994; Meikrantz and Schlegel, 1996; Shi et al., 1996;
Harvey et al., 1998; Levkau et al., 1998; Zhou et al.,
1998). We find that the death-associated Cdk activity in
HeLa cells is fully depleted from crude extracts using an
anti-Cdk2 antibody (Fig. 1 C) and exhibits other diagnos-
tic characteristics of Cdk2, including complete inhibition
by 50 
 
m
 
M olomoucine (Glab et al., 1994) and a K
 
m
 
 for
peptide substrate of 12 
 
m
 
M (vs. 8 
 
m
 
M for purified Cdk1;
data not shown). The induction of Cdk2 activity (Fig. 1
B), like caspase activity (Fig. 1 A) and morphological
manifestations of death (see below), is inhibited when
cells are cultured in the presence of the pan-caspase pep-
tide inhibitor, z-VAD-fmk. These data confirm that HeLa
cells rely on the caspase-dependent pathway of death
and, most significantly, demonstrate that death-associ-
ated Cdk2 activity is dependent on, and downstream of,
the caspase cascade.
 
Death-associated Chromatin Condensation Is 
Dependent on Cdk Activity
 
Dominant negative Cdk mutants have been shown to ar-
rest transfectant cells in the specific phase of the cell cycle
in which the functional Cdk normally acts (van den Heu-
vel and Harlow, 1993). These mutants lack kinase activity
(due to substitution of the active site aspartate with as-
pargine [D
 
145
 
®
 
N for huCdk2]) and act in a dominant neg-
ative manner due to their ability to compete with endoge-
nous wild-type Cdks for binding of necessary partner
cyclins (van den Heuvel and Harlow, 1993).
We find that DN-Cdks exert appropriately similar phe-
notypes in transfected HeLa cells (Fig. 2). Expression of
DN-Cdk1, a mutant of the mitotic Cdk whose primary ac-
tivating partner is cyclin B, significantly increases the num-
ber of cells in the G
 
2
 
/M compartment (Fig. 2 B). DN-
Cdk2, a mutant of the Cdk that acts at the G1/S transition
or during S phase when complexed with cyclins E or A re-
spectively, arrests cells efficiently at the G1/S boundary
(Fig. 2 C). Expression of DN-Cdk3, a mutant of a less well
characterized Cdk that interacts with cyclin A (Meikrantz
and Schlegel, 1996), has only a modest effect on cell cycle
progression (Fig. 2 D). DN-Cdk4, a mutant of a Cdk that
has been implicated recently in G2 phase control (Gabri-
elli et al., 1999), expands the number of cells in that phase
of the cycle (Fig. 2 E). The primary role of Cdk4 in regu-
lating exit from G1 through the cyclin D-dependent Rb
pathway is not evident in HeLa cells, consistent with the
inactivation of Rb proteins by the HPV viral oncogene E7
(Munger et al., 1989; Matsushime et al., 1994).
This demonstration of functional expression of DN-
Cdks in HeLa cells allowed us to probe the specific roles
of Cdks in the cell death process. After transfection, cells
were treated with TNF-a or staurosporine, or left un-
treated (see Materials and Methods). Our hypothesis that
Cdks might be involved especially in the nuclear events of
cell death led us first to examine death-associated chroma-
tin condensation. Chromatin condensation, as indicated by
Figure 2. DN-Cdk mutants
arrest HeLa cells in the cell
cycle compartment in which
the endogenous wild-type Cdk
acts. HeLa cells were cotrans-
fected with EGFP-F and
empty vector (A), DN-Cdk1
(B), DN-Cdk2 (C), DN-Cdk3
(D), and DN-Cdk4 (E). Cells
were harvested, fixed and
stained with propidium io-
dide to assess DNA content.
At least 10,000 EGFP-F1
cells were analyzed. In paral-
lel, untransfected cells were
subjected to a double thymi-
dine block and analyzed (F).The Journal of Cell Biology, Volume 148, 2000 64
enhanced Hoechst 33342 staining intensity, was assessed in
EGFP-F1 cells (see Fig. 3).
Expression of DN-Cdk2 inhibited chromatin condensa-
tion induced by TNF-a and by staurosporine (Figs. 3, 4,
and 5 A). DN-Cdk3 expression was equally effective (Figs.
4 and 5 A). In contrast, the expression of DN-Cdk1 or
DN-Cdk4 had no significant inhibitory effect (Figs. 4 and 5
A). These data are consistent with the biochemical identi-
fication of death-associated Cdk2 activity (Fig. 1 C) and
implicate Cdk2 as required for death-associated chromatin
condensation. An independent role of Cdk3 in this cell
death process cannot be excluded (see Discussion). The
overexpression of p21Cip1/Waf1 or p27Kip1, CKIs that target
Cdk2, also abrogated staurosporine- and, to a lesser de-
gree, TNF-a–induced chromatin condensation (Figs. 4 and
5 A, and data not shown). On the other hand, the relative
inability of p16Ink4a, a specific inhibitor of Cdk4, to inhibit
chromatin condensation is consistent with DN-Cdk4 data
in suggesting no significant role for Cdk4 in HeLa cell
death (Figs. 4 and 5 A; see below).
The blockade of chromatin condensation afforded by
Cdk2 inhibition is comparable to that resulting from cas-
pase inhibition. Overexpression of the viral serpin CrmA,
a specific inhibitor of initiator caspase activity, prevented
death-associated chromatin condensation (Figs. 3, 4, and 5
A). We obtained similar results with the broader spectrum
caspase inhibitor, p35 (data not shown). Interestingly, the
human oncogene Bcl-2 inhibited chromatin condensation
induced by staurosporine but not by TNF-a (Figs. 4 and 5
A). This is consistent with other reports of the inability of
Bcl-2 to interfere with death signaled via receptors of the
TNF-a superfamily in a manner independent of mitochon-
drial events (Memon et al., 1995; Strasser et al., 1995;
Dbaibo et al., 1997). Together, these data confirm that
caspases are necessary generally for cell death–associated
chromatin condensation, although distinct caspase cas-
cades are activated by different stimuli, and extend this
conclusion to suggest that, independent of the specific
death stimulus, it is the caspase-dependent activation of
Cdks that drives this nuclear manifestation of the death
process.
Other Apoptotic Events Are Dependent on Cdk Activity
We explored the death response more completely in these
transfectants by examining other manifestations of cellular
demise. We observed that cells with condensed chromatin
typically exhibited a shrunken, rounded cellular morphol-
Figure 3. Caspase and Cdk activities are necessary for death-associated chromatin condensation and cell shrinkage. Transfectants were
identified by fluorescence microscopy, by virtue of expression of the cotransfection marker EGFP-F, which is retained in dying cells
(A–D). Chromatin condensation, assessed microscopically by the intensity of Hoechst 33342 staining, was visualized microscopically
(E–H). Cell shrinkage and the loss of adhesion are revealed here by the condensation and rounding of EGFP-F staining (A–D). These
manifestations of death were assessed in untreated cells previously transfected with empty vector (A and E) and in cells transfected
with empty vector (B and F), CrmA (C and G), and DN-Cdk2 (D and H) and subsequently treated for 7 h with 10 ng TNF-a in the pres-
ence of a nonlethal dose (3 mg/ml) of cycloheximide. The evaluation of cellular morphology by EGFP-F staining yields results identical
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ogy and the loss of substrate adhesion, as assessed by
phase contrast microscopy. In addition, we noted that one
consequence of cell shrinkage and rounding in EGFP-F1
transfectants is a condensed EGFP-F signal (see Fig. 3 and
Materials and Methods). We find that this EGFP-F con-
densation is a quantitative and reliable correlate of cellu-
lar collapse (see Materials and Methods).
Remarkably, not only chromatin condensation but also
cellular rounding, EGFP-F condensation, and the loss of
adherence are blocked by Cdk inhibition (see Fig. 3). Fig.
5 demonstrates the concordance of these distinct aspects
of the cell death process. In this case, where cells were
treated with TNF-a, CrmA but not Bcl-2 prevented cellu-
lar as well as chromatin condensation. The inhibition of
caspases by the expression of p35 also abolished death and
condensation (data not shown). Inhibition of Cdk2 activity
comparably inhibited nuclear events and cell shrinkage
equivalently, while the expression of either DN-Cdk1 or
DN-Cdk4 exerted only minor effects. The expression of
CKIs targeting Cdk2 similarly was effective in preventing
condensation. In contrast, and as suggested in the analysis
of chromatin condensation (Figs. 4 and 5 A), transfection
of p16Ink4a itself elicits cell death in these transformed
cells (Sandig et al., 1997; Schreiber et al., 1998). In these
transient experiments, expression of EGFP-F could be
followed for at least 5 d. DN-Cdk2 and DN-Cdk3 trans-
fectants remained intact, adherent, and uncondensed
throughout this period; their continued ability to exclude
propidium iodide (data not shown) confirmed their integ-
rity. Indeed, as long as EGFP-F expression was detected,
the ability of the DN-Cdks to prevent nuclear and cellular
condensation was unabated. In this regard, the blockade
of death-associated events by DN-Cdk2 and DN-Cdk3
was no less complete than the death-sparing effect of
CrmA.
We have observed the strict correlation of chromatin
condensation and cellular collapse, and the sparing of both
by Cdk inhibition, after treatment with other suicidal stim-
uli including staurosporine (data not shown). That Cdk ac-
tivity plays a requisite role in death-associated chromatin
condensation provides support for the hypothesis that par-
allels may exist between the cell death– and cell cycle–
related processes. These data, moreover, are consistent
with the notion that the induction of chromatin condensa-
tion in response to a death signal is intimately linked to
other manifestations of cellular disintegration, and extend
our hypothesis that caspase-dependent Cdk activity may
be an effector of death.
Figure 4. The inhibition of Cdk2 activity prevents
staurosporine-induced chromatin condensation.
Chromatin condensation was assessed in cells trans-
fected with the indicated vectors (u, j) or in un-
transfected cells ( ) synchronized by double thymi-
dine block or incubated with the pan-caspase
inhibitor z-VAD-fmk (100 mM; see Fig. 1). Cells were
treated with staurosporine (1 mM; j,  ) or left un-
treated (u), and chromatin condensation was as-
sessed after 7 h. The percentage of transfected
(EGFP-F1) or untransfected cells with condensed
chromatin was assessed microscopically (see Fig. 3).
The data shown represent one of three replicate ex-
periments where each sample is the average of three
microscopic fields of at least 100 cells of interest
each.
Figure 5. The inhibition of Cdk2 activity prevents TNF-a–
induced cell death manifestations. Cells transfected with the indi-
cated vectors were treated with 10 ng TNF-a in the presence of 3
mg/ml of cycloheximide (as in Fig. 3; j), or left untreated (u).
After 7 h, the percentages of transfected (EGFP-F1) cells with
condensed chromatin (A) and with shrunken, nonadherent mor-
phology, as assessed both by phase contrast microscopy and the
condensation of EGFP-F staining (B) were quantified. The data
shown represent one of three replicate transfections, where each
sample is the average of three microscopic fields of at least 100
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Cdks Act Downstream of Caspase Activation As 
Requisite Effectors of Cell Death Events
That Cdks, acting to promote cell cycle progression, can
modulate cellular susceptibility to death (Galaktionov et al.,
1996; Luo et al., 1996; Hakem et al., 1999) raises the possi-
bility that the abolition of cellular condensation resulting
from the inhibition of Cdk activity might reflect resistance
to the induction of death conferred by cell cycle arrest. If
so, alternative means of arresting cells should mimic this
death resistance. HeLa cells were arrested at the G1/S
boundary using a double thymidine block (Fig. 2 F) or at
an earlier stage in G1 by serum starvation (data not
shown). Unlike transfectants that are arrested by DN-
Cdk2 expression (Fig. 2 C), thymidine-arrested and se-
rum-starved cells retained susceptibility to TNF-a– and
staurosporine-induced chromatin condensation and death
(Figs. 4 and 5, and data not shown). These results demon-
strate that cell cycle arrest per se is not sufficient to inhibit
death and suggest that the sparing effects of DN-Cdks do
not relate simply to the restriction of cells in an insensitive
compartment of the cell cycle.
The more definitive question is whether DN-Cdks exert
their sparing effects by targeting caspase-dependent Cdk
activity. If Cdk inhibition alters late steps of the death
pathway but not its initiation, events upstream of Cdk acti-
vation should ensue unimpaired. We took two different
approaches to test whether effector caspases are activated
in transfectants expressing DN-Cdks. We employed an in
vivo fluorogenic DEVD peptide substrate (PhiPhiLux-
G2D2; Packard et al., 1996) to probe caspase 3–like caspase
activity microscopically and cytofluorimetrically in EGFP-
F1 cells (see Materials and Methods). We also tested bio-
chemically whether effector caspase activity was able to
cleave a cotransfected substrate protein.
The in vivo fluorogenic substrate revealed effector
caspase activity in cells induced to die by TNF-a and by
staurosporine, but not in untreated controls (Figs. 6 and
7). The mean fluorescence intensity of the PhiPhiLux-
G2D2 signal (580 nm) in caspase-positive cells typically
was seven to eightfold greater than that of caspase-nega-
tive control cells; this compares with the z20-fold peak in-
duction in total DEVD-specific activity seen in vitro (Fig.
1 A). The reduction in the number of caspase-positive cells
resulting from the transfection of caspase inhibitors CrmA
(Fig. 7) and p35 (data not shown) confirms the validity of
this assay, and the cytoplasmic localization of the fluores-
cent signal (Fig. 6) agrees with our previous biochemical
fractionation studies (Harvey et al., 1998). Strikingly,
death stimuli still induced caspase activity in cells trans-
fected with DN-Cdk2 or DN-Cdk3 (Figs. 6 and 7).
Caspase activity in these transfectants, assessed by PhiPhi-
Lux-G2D2 signal intensity, was unaltered relative to con-
trol (e.g., vector only) transfectants.
The analysis of caspase-dependent protein cleavage
gave results entirely consistent. Several recent reports
have documented the caspase-dependent cleavage in
dying human cells of the CKIs, p21Cip1/Waf1 and p27Kip1
(Gervais et al., 1998; Levkau et al., 1998; Zhang et al.,
1999). The cleavage by caspase 3 of p21Cip1/Waf1 at
AEEDHVD112LSL results in 14- and 7-kD peptides that
separate the NH2-terminal cyclin/Cdk interacting domain
from the COOH-terminal PCNA interacting domain
(Chen et al., 1995; Adams et al., 1996). We have observed
that deletions within the NH2-terminal region of p21Cip1/Waf1
abrogate the death-inhibitory activity of the molecule
without altering its susceptibility to caspase cleavage. A
p21Cip1/Waf1 mutant, deleted for amino acids 17 through 52,
and fused in-frame to a hemagglutinin (HA) epitope tag,
Figure 6. Death-associated caspase activity and chromatin condensation, visualized in vivo, are dissociated by DN-Cdk2 expression.
Cells cotransfected with EGFP-F and empty vector (A and B) or DN-Cdk2 (C) were left untreated (A) or treated for 4 h with TNF-a
(B and C). Cells then were analyzed microscopically for nuclear condensation (Hoechst 33342 staining; blue), effector caspase activity
(in vivo fluorogenic DEVD peptide substrate, PhiPhiLux-G2D2; red), and expression of EGFP-F (green, not shown). Each of the cells
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provided an excellent probe with which to test caspase
function in transfected cells. While p21Cip1/Waf1D17-52-HA
itself did not prevent cell death, it had no effect on the
ability of DN-Cdk2 to spare cells from death-associated
events induced by TNF-a or by staurosporine (Harvey,
K.J., D. Lukovic, and D.S. Ucker, manuscript in prepara-
tion).
As shown in Fig. 7 C, caspase-dependent cleavage of the
mutant p21Cip1/Waf1 molecule ensued even when cells were
spared by DN-Cdk2 expression. The z14-kD fragment,
revealed with an antibody specific for an NH2-terminal
p21Cip1/Waf1 peptide, is diagnostic of this cleavage. This
cleavage product was visible even in untreated transfec-
tants, reflecting the background of dead cells in trans-
fectant populations (see Materials and Methods). Death
stimuli triggered a substantial increase in the relative
abundance of the z14-kD product, and a correspond-
ing diminution of the full-length molecule. Cleavage of
p21Cip1/Waf1 was triggered identically in the DN-Cdk2
transfectants (Fig. 7 C). In contrast, cell death inhibitors
that act within the caspase cascade, such as CrmA, elimi-
nated even the background of p21Cip1/Waf1 cleavage (Fig. 7
C). We observed a similar correspondence between the
full-length p21Cip1/Waf1D17-52-HA band and the comple-
mentary 7-kD COOH-terminal cleavage fragment in par-
allel blots developed with an antibody specific for the HA
epitope (data not shown). The 7-kD fragment is much less
abundant, however, reflecting apparent degradation by
non-caspase proteases at COOH-terminal sites. These
data argue that requisite Cdk function is downstream of
the caspase cascade, consistent with the view that it is the
Cdk activity we characterized as caspase dependent whose
function is essential for death-associated cellular conden-
sation. The proteolytic caspase cascade, while necessary, is
not sufficient for the full physiological cell death program.
Dissociation of Mitochondrial and Other Direct Effects 
of Caspases from Cdk-dependent Death Events
Just as caspases remain active in cells in which down-
Figure 7. DN-Cdk2 blocks cell death events through its action
downstream of caspase activation. The induction of effector
caspase activity was assessed with the in vivo fluorogenic DEVD
peptide substrate PhiPhiLux-G2D2 in EGFP-F1 transfectants by
dual color cytofluorimetry. At least 5,000 EGFP-F1 cells were
analyzed after 4 h of treatment with TNF-a (j; A) or staurospo-
rine ( ; B) and in untreated controls (u). PhiPhiLux-G2D2 was
included during the last hour of incubation (see Materials and
Methods). Independently, caspase cleavage of cotransfected and
epitope-tagged p21Cip1/Waf1 mutant was monitored by Western
blotting of cellular extracts (C). Extracts were prepared from
cells transfected with p21Cip1/Waf1D17-52-HA alone or together
with DN-Cdk2 or CrmA, and from mock-transfected cells. Cells
were left untreated (u) or were treated for 4 h with TNF-a (t) or
staurosporine (s). Both the intact p21Cip1/Waf1D17-52-HA mole-
cule and its NH2-terminal 14-kD caspase cleavage fragment are
visualized here with an antibody specific for a p21Cip1/Waf1 peptide
(amino acids 58–77). Note that endogenous wild-type p21Cip1/Waf1
is not visible at this level of sensitivity.
Figure 8. The caspase-dependent loss of membrane phospholipid
asymmetry is not blocked by Cdk inhibition. The loss of plasma
membrane phosphatidylserine asymmetry was assessed as the ex-
tent of binding of annexin V-PE to EGFP-F1 transfectants by
dual color cytofluorimetry. At least 5,000 EGFP-F1 cells were
analyzed after 4 h of staurosporine treatment (j) and in un-
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stream Cdk activity is inhibited, caspase-proximal events
that are upstream or independent of Cdks would be pre-
dicted to proceed unimpaired in DN-Cdk transfectants.
The loss of the asymmetric distribution of phosphati-
dylserine between the inner and outer leaflet of the cyto-
plasmic membrane is associated with cell death, and may
be involved in the recognition of dying cells by phagocytic
macrophage (Fadok et al., 1992). We examined the loss
of plasma membrane phosphatidylserine asymmetry in-
duced by staurosporine (Fig. 8) in DN-Cdk transfectants.
Externalization of phosphatidylserine was measured cyto-
fluorimetrically by the extent of binding of PE-conjugated
annexin V on EGFP-F1 cells. Bcl-2 and CrmA transfec-
tants were not induced to become annexin V-positive after
treatment with staurosporine (Fig. 8), consistent with the
action of these death inhibitors to block caspase activity
(Fig. 7). In contrast, and as seen with the induction of
caspase activity, cells spared from death-associated con-
densation by transfected DN-Cdk2 or DN-Cdk3 were un-
impeded in their ability to expose phosphatidylserine on
the outer leaflet of the cytoplasmic membrane (Fig. 8).
The disruption of mitochondrial integrity has been im-
plicated as a central event in the physiological cell death
process (Marchetti et al., 1996; Zamzami et al., 1996; Susin
et al., 1997). The release of cytochrome c from the in-
tramembrane space may be an early determinative step,
and the loss of mitochondrial membrane potential (DCm)
and liberation of another death mediator, apoptosis induc-
ing factor (AIF), have been reported to occur subse-
quently, possibly in a caspase-dependent manner (Mar-
chetti et al., 1996; Zamzami et al., 1996; Susin et al., 1997,
1999). We measured DCm by monitoring the intensity of
fluorescence of the mitochondrial membrane potential-
specific probe tetramethylrhodamine ethyl ester (TMRE;
Farkas et al., 1989) in EGFP-F1 transfectants.
We observed profound mitochondrial depolarization in
HeLa cells dying in response to treatment with staurospo-
rine or TNF-a. The magnitude of this drop in mitochon-
drial membrane potential was equal in intensity to that
caused by pharmacologic depolarization triggered by the
mitochondria-specific ionophore carbonyl cyanide m-chlo-
rophenylhydrazone (ClCCP; data not shown). Transfec-
tants expressing caspase inhibitors CrmA and p35, that
were spared from TNF-a– and staurosporine-mediated
death, did not suffer this loss of membrane potential (Fig.
9, A and B, and data not shown). In contrast, the loss of
mitochondrial membrane potential induced by staurospo-
rine or TNF-a was not prevented in DN-Cdk2 and DN-
Cdk3 transfectants (Fig. 9, A and B). As seen in the analy-
sis of caspase activity, the inhibition of caspase-dependent
Cdk activity by DN-Cdk transfection prevents cellular
condensation without affecting upstream events.
Direct depolarization of mitochondria with ClCCP also
results in a typical apoptotic cell death (Zamzami et al.,
1996). That this death response is not due simply to DCm is
suggested by the observation that death is induced only at
a dose of ClCCP (30–100 mM) at least 10-fold higher than
the minimal dose needed for full depolarization (data not
shown), and by the ability of Bcl-2 to inhibit ClCCP-
induced death (Zamzami et al., 1996; Fig. 9 C). As demon-
strated by the death-sparing effect of p35 (Fig. 9 C),
ClCCP induced a caspase-dependent death process. In
contrast to p35, CrmA did not spare ClCCP-induced death
(Fig. 9 C); the ability of this mitochondrial agent to initiate
a death response appears to obviate the requirement for
upstream caspase activity. Here too, inhibition of Cdk ac-
tivity downstream of the caspase cascade attenuated chro-
matin condensation, even in the absence of mitochondrial
membrane potential (Fig. 9 C and data not shown). These
Figure 9. The inhibition of Cdk2 blocks chromatin condensation
independent of mitochondrial disruption. Loss of mitochondrial
membrane potential (DCm) was assessed by the intensity of
TMRE fluorescence in EGFP-F1 transfectants by dual color
cytofluorimetry. At least 5,000 EGFP-F1 cells were analyzed af-
ter 4 h of treatment with TNF-a (j; A) or staurosporine ( ; B)
and in untreated controls (u). Chromatin condensation was as-
sessed after 9 h of treatment with 200 mM of ClCCP ( ) and in
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data reveal that the action of Cdks downstream of cas-
pases represents a conserved phase of the cell death pro-
cess, closely linked with actual lethality.
Discussion
Mapping Cdk Function Identifies a Point of Cell Death 
Commitment Downstream of Caspases
The results of our experiments testing the necessity of Cdk
activity in cell death are striking. As in other cells, death-
associated Cdk2 activity is induced in a caspase-dependent
manner in HeLa cells. We imagined that the inhibition of
Cdk2 activity might prevent apoptotic chromatin conden-
sation. Indeed, transfection of DN-Cdk2 does prevent the
chromatin condensation triggered by different suicidal
stimuli, including TNF-a and staurosporine. CKIs that bind
Cdk2, such as p27Kip1 and p21Cip1/Waf1, exert a similar inhib-
itory effect. Cdk2 inhibition prevents death-associated
chromatin condensation as effectively as the established
death-inhibitory gene products Bcl-2, CrmA, and p35. The
inhibition afforded by DN-Cdk3 may indicate an addi-
tional role for Cdk3 within the cell death process. Alterna-
tively, DN-Cdk3 may inhibit Cdk2 indirectly by virtue of
its ability to bind cyclin A (Meikrantz and Schlegel, 1996).
This would be consistent with the participation of cyclin A
in the death-associated Cdk2 complex (see Fig. 1 C;
Meikrantz et al., 1994; Harvey et al., 1998).
A necessary role for Cdks in the physiological cell death
process had been suggested by a number of studies, espe-
cially using anti-sense and dominant negative approaches,
to functionally ablate specific Cdk activity (Shi et al., 1994;
Fotedar et al., 1995; Meikrantz and Schlegel, 1996; Park
et al., 1998). However, those studies could not distinguish
where within a death pathway required Cdks might func-
tion. Cell cycle transit is a necessary component of several
death responses, including myc- and Cdc25A-dependent
factor deprivation (Galaktionov et al., 1996) and activa-
tion-driven lymphocyte deletion (Fournel et al., 1996;
Radvanyi et al., 1996; Hakem et al., 1999). In these partic-
ular cases of cell death, Cdks serve an essential function in
a modulatory capacity, upstream of Bcl-2 and the caspase
cascade. The recent characterization of the mammalian in-
hibitor of apoptosis (IAP), survivin, as a mitotic check-
point protein suggests that cellular sensing mechanisms
exist to signal and initiate the physiological cell death pro-
cess directly upon detection of aberrant Cdk activation or
irregular cell cycle progression (Li et al., 1998).
This modulatory Cdk function is distinct from the role
of Cdks that we have characterized here. The results of
our experiments indicate that transient ablation of Cdk ac-
tivity does not alter the induction steps of the cell death
pathway that precede Cdk activation, including down-
stream effector caspase activity. That DN-Cdk transfec-
tants still exhibit a subset of the caspase-dependent fea-
tures typically associated with cell death indicates that
caspases indeed are active, and that the activation of
caspases alone is not sufficient to effect the full physiologi-
cal cell death program.
We previously attributed a nonlethal regulatory func-
tion to upstream caspase activity, based on the ability of
Bcl-2 to spare cells from death without interfering with
that activity (Harvey et al., 1998). Our new data similarly
ascribe an essential role to downstream caspase activity
that is not entirely sufficient. That Cdk activity is depen-
dent on downstream caspase activity and is necessary for
death-associated events suggests that nuclear Cdk activity
may be a critical lethal effector of the process, and that its
caspase-dependent activation represents a point of com-
mitment in the process of cell death. In recapitulating the
functional ordering of death activities we accomplished
previously with stable transfectant clones, these data con-
firm the efficacy of the transient transfection strategy em-
ployed here and demonstrate that the thematically con-
served pathway of death pertains in non-lymphoid cells as
well.
The Mechanism of Caspase-dependent Cdk Activation
Recent data support the view that the induction of death-
associated Cdk activity may depend on the proteolytic
destruction of negative regulators of Cdk activity by
caspases. The caspase-dependent cleavage of Cdc27, a
necessary component of the complex that targets cyclins
for ubiquitin-dependent elimination, has been described in
human Jurkat T cells (Zhou et al., 1998). Cdc27 destruc-
tion could be responsible for the elevated levels of cyclin
A that we have described previously in dying lymphocytes
(Harvey et al., 1998); it is notable that forced cyclin A
overexpression is lethal (Meikrantz and Schlegel, 1996;
Harvey, K.J., unpublished observations). That we have not
observed changes in the gross levels of cyclin A or Cdk2
mRNA levels in dying cells (Harvey et al., 1998) sug-
gests, more generally, that the induction of death-associ-
ated Cdk activity occurs primarily on a posttranslational
level (Chang, S.H., K.J. Harvey, and D.S. Ucker, manu-
script in preparation).
The caspase-dependent destruction of Wee1, the Cdk-
inhibitory kinase, also has been noted in Jurkat cells
(Zhou et al., 1998). However, we have not observed cor-
responding phosphorylation-specific mobility changes in
death-associated Cdk2 in dying lymphocytes or HeLa cells
(Harvey et al., 1998; Harvey, K.J., unpublished observa-
tion). The suggestion that caspase-mediated cleavage of
the CKIs p21Cip1/Waf1 and p27Kip1 (Gervais et al., 1998;
Levkau et al., 1998; Zhang et al., 1999) could be an impor-
tant mechanism for death-associated Cdk activation is not
inconsistent with the abilities of overexpressed p21Cip1/Waf1
and p27Kip1 to inhibit cell death responses. We note that
the human p21Cip1/Waf1 cleavage site is not present in the
murine p21Cip1/Waf1 (APEDHVA110LSL).
The sparing effects exerted in HeLa cells by the over-
expression of p21Cip1/Waf1 and p27Kip1 contrasts with re-
sults described by Levkau et al. (1998), in which factor-
deprived HUVEC cells were spared only by ectopic
expression of a noncleavable mutant of p21Cip1/Waf1. In our
experiments, we have observed that caspase-cleavable
CKIs are effective death inhibitors. We have found, more-
over, that these cleavable CKIs are able to competitively
inhibit caspase activity in certain cases, suggesting that
CKIs may act at multiple levels to inhibit cell death (Har-
vey, K.D., D. Lukovic, and D.S. Ucker, manuscript in
preparation). It is intriguing that the death-sparing efficacy
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to the relative involvement of receptor-coupled and mito-
chondria-dependent caspase cascades in different death
responses. p21Cip1/Waf1 is more effective at inhibiting death
induced by staurosporine than by TNF-a, although the in-
hibition of these two responses by DN-Cdk2 is equivalent.
That Bcl-2 blocks TNF-a–induced mitochondrial depolar-
ization and caspase 3–specific activity but not death sug-
gests that, in HeLa cells, TNF-a triggers a lethal caspase
cascade directly through its receptor (presumably coupled
to caspase 8), and that a secondary, mitochondria-depen-
dent and Bcl-2 inhibitable cascade that involves caspases 9
and 3 is initiated but is not essential. In all cases, however,
the activation of caspases is insufficient to complete the
full cell death program.
The Role of Cdks in Effecting Cell Death
The precise function of caspase-dependent Cdk activity
in effecting apoptotic events remains to be determined.
Whereas the link of death-associated Cdk activation and
chromatin condensation fulfills the hypothesis that the
processes of cell death and division may be related mecha-
nistically, cell death is not simply an out-of phase mitotic
catastrophe: mitotic cyclin B/Cdk1 complexes are not ac-
tive (Harvey et al., 1998) and other markers of mitosis, in-
cluding typical mitotic histone H3 phosphorylation, have
not been detected in dying cells (Hendzel et al., 1998;
Zhou et al., 1998). On the other hand, the insufficiency of
caspases in this regard suggests that neither is chromatin
condensation, simply the consequence of the proteolytic
activation of endonucleases such as CAD (Enari et al.,
1998; Sakahira et al., 1998), for instance. Of course, ge-
nome digestion is dispensable for physiological cell death
(Ucker et al., 1992; Samejima et al., 1998; Zhang et al.,
1998), and many cells do not degrade their genomes exten-
sively when they die (Gromkowski et al., 1986; Howell and
Martz, 1987; Ucker et al., 1992). We have not detected ex-
tensive DNA degradation in HeLa cells, as assessed by the
appearance of a population of cells with sub-diploid DNA
content or by measures of DNA strand breaks (Harvey,
K.J., unpublished data). It remains to be determined
whether caspase-dependent genome digestion can ensue
in the absence of chromatin condensation, and whether
other Cdk-regulated processes are necessary.
More generally, the control of the intracellular localiza-
tion, particularly to the nucleus, of relevant molecules dur-
ing the cell death process (Yasuhara et al., 1997) may be
dependent on Cdk activity. The nuclear recruitment of cy-
clin A itself appears to be a caspase-dependent phenome-
non (Harvey et al., 1998). We hypothesize that the dissolu-
tion of the nuclear envelope, including the solubilization
of the lamin meshwork that resides within that envelope
(Ucker et al., 1992; Lazebnik et al., 1995; Rao et al., 1996),
depends primarily on the activity of nuclear Cdks and not
on extranuclear caspases. It will be of value to examine
further the involvement of other cell cycle components
within the cell death process. Condensins, Cdk regulable
complexes both necessary and sufficient for mitotic chro-
matin condensation in cell free assays (Hirano et al., 1997;
Kimura et al., 1998), are of obvious interest. Sites for acti-
vating phosphorylation by Cdk1 that have been identified
in one condensin subunit (Kimura et al., 1998) may be tar-
geted by death-associated Cdk2, for example. Finally, the
insufficiency of caspases suggests that alternative means of
activating Cdks might be able to trigger physiological cell
deaths that are caspase-independent (Heald et al., 1993;
Blasina et al., 1997).
Defining Death
We have refined our mapping of the cell death pathway
using end-point markers that include chromatin condensa-
tion and the loss of cellular adhesion to substrate. In this
context, caspase-proximal events are not sufficient to as-
sure the full physiological cell death program. An opera-
tional definition of lethality, and the point of death com-
mitment, is circumscribed by the measures of death
employed, of course; it is clear that the demise of a cell
must be inevitable, albeit not necessarily apoptotic, when
its mitochondria are depolarized and abundant proteolytic
activity is present. Still, the precise issue is whether cellu-
lar disintegration in the absence of caspase-dependent
Cdk activity represents a concerted physiological process.
If the externalization of phosphatidylserine were to be all
that is needed for phagocytic recognition, for example,
then activation of caspases upstream of Cdks would repre-
sent death commitment. Our experiments to date indicate
that the loss of asymmetry of phosphatidylserine distribu-
tion is not sufficient for macrophage recognition (Cocco,
R.E., and D.S. Ucker, manuscript in preparation). The
ultimate purpose of physiological cell death is to facili-
tate the noninflammatory clearance of inappropriate cells
(Ucker, 1997). This must be the criterion by which the
point of death commitment is assessed finally.
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